What Dollvet does

Dollvet Biyoteknoloji is a privately held Turkish biotechnology company founded in 2002 that manufactures veterinary biological products including vaccines, test antigens, hyperimmune sera, and diagnostic kits. The company operates a 38,000 square meter GMP-certified production campus in Şanlıurfa, Turkey, with corporate headquarters in the Beşiktaş district of Istanbul. Its portfolio spans more than 60 different products exported to over 30 countries across the Middle East, Central Asia, and Africa, including foot-and-mouth disease (FMD) vaccines, ruminant vaccines, and — most recently — Resolid CAT, Turkey's first domestically produced combined feline vaccine. The company holds GMP certification and an R&D certificate from Turkey's Ministry of Industry and Trade, positioning it as one of the country's internationally recognized veterinary biologics producers.

Dollvet operates a hybrid B2B and B2G go-to-market model. Domestically, it maintains a nationwide direct field sales network of approximately 20 regional sales representatives and field technical managers covering all major Turkish regions, most of whom are veterinary doctors or agricultural engineers providing on-site technical support to veterinary clinics, livestock farms, and pet owners. Internationally, the company sells through large-scale government procurement contracts — exemplified by its 6 million-dose FMD vaccine shipment to South Africa's Department of Agriculture as part of a national vaccination campaign targeting 14 million cattle — supplemented by a dedicated international relations and export team engaging with government animal health authorities in the Middle East, Central Asia, and Africa. The company also invests in brand building through industry event sponsorships (VIV MEA Abu Dhabi 2025, GFRA Scientific Meeting 2025, PPR Vaccine Manufacturers Global Meeting) and active media engagement around product launches.

The company's revenue base is anchored by recurring livestock vaccine demand from Turkish farmers and export sales to government animal health authorities. Key customers include the South Africa Department of Agriculture and the broader category of government veterinary services in 30+ countries. The company is privately held with no disclosed parent company, institutional investors, or public funding rounds; ownership structure is not publicly documented. Recent strategic activity has focused on companion animal market entry (Resolid CAT launch in June 2026), African and Central Asian geographic expansion, and multi-source positioning in international FMD vaccine tenders alongside established competitors such as Argentina's Biogénesis Bagó.

Name

Dollvet

Legal name

Dollvet Biyoteknoloji

Website

https://dollvet.com.tr

Company type

Private

Founded year

2002

Operating status

Operating

Headcount range

101–250 employees

Short description

Dollvet is a Turkish GMP-certified veterinary biologics manufacturer producing vaccines, test antigens, hyperimmune sera, and diagnostic kits from a 38,000 sqm facility in Şanlıurfa, exporting 60+ products to 30+ countries and serving government animal health authorities, livestock operators, and veterinary clinics.

Ownership category

akta.pro rank

Product category

Veterinary Biologicals

NAICS

Biological Product (except Diagnostic) Manufacturing (325414), Pharmaceutical Preparation Manufacturing (325412)

SIC

Biological Products, (No Disgnostic Substances) (2836), Pharmaceutical Preparations (2834)

akta.pro primary industry

Vaccine Manufacturing & Contract Services (Veterinary Vaccine CDMO) (HLAMAKAI)

akta.pro secondary industries

Veterinary Vaccines (Biologics) (HLAMAEAL), Vaccine R&D, Clinical/Field Trials & Regulatory Affairs (HLAMAKAM), Veterinary Vaccines (HLAIAEAH)

Keywords

• Veterinary vaccines
• Animal biologicals
• Diagnostic antigens
• Hyperimmune sera
• Livestock health

Headquarters

HQ city

Besiktas

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Personnel, Technology or R&D, Marketing or Sales, Supply Chain

Revenue model

1. Veterinary Vaccine Sales: Dollvet generates revenue primarily through the manufacture and sale of veterinary biological products including vaccines, diagnostic antigens, hyperimmune sera, and diagnostic kits to government agencies, veterinary clinics, farms, and livestock operators. International government procurement contracts (e.g., South Africa FMD vaccine orders) represent a significant revenue stream.
2. International Export Sales: Export of veterinary vaccines to international markets, including large-scale government procurement orders such as the 6 million-dose FMD vaccine order from Turkey's Dollvet to South Africa, and shipments to other countries in the Middle East, Central Asia, and Africa.

Go-to-market motion2 records

Distribution channels2 records

Marketing channels3 records

Core offering

Dollvet manufactures veterinary vaccines, test antigens, hyperimmune sera, and diagnostic kits at its GMP-certified 38,000 sqm production campus in Şanlıurfa, Turkey. The company markets 60+ biotechnology products domestically and exports to 30+ countries, including large-scale government procurement orders such as foot-and-mouth disease (FMD) vaccines for national vaccination programs.

Product overview

Dollvet is a biotechnology company producing high-quality biotechnology products for human, animal, and environmental health protection. Their product portfolio includes four main categories: vaccines (aşılar), test antigens (test antijenleri), hyperimmune sera (hiperimmun serumlar), and diagnostic kits (tanı kitleri). The company operates from a 38,000+ square meter GMP-certified production campus in Şanlıurfa, Turkey, and exports to over 30 countries. Notable products include Resolid CAT, Turkey's first domestic cat combined vaccine. Dollvet serves both domestic and international markets with their animal health biotechnology products.

Differentiator

Problem solved

Functional benefit

Brands

• Resolid CAT: Turkey's first domestic combined cat vaccine
• İmmudoll CG

Products and services

• Veterinary Vaccines (Aşılar) Vaccines produced by Dollvet for animal health protection, including foot-and-mouth disease (FMD) vaccines and other livestock immunizations, sold to government animal health authorities, veterinary clinics, farms, and livestock operators.
• Test Antigens (Test Antijenleri) Test antigens used for diagnostic purposes in veterinary medicine, supporting livestock health management and disease detection programs.
• Hyperimmune Sera (Hiperimmun Serumlar) Hyperimmune sera products for therapeutic and preventive applications in animal health, used by veterinarians and livestock operators.
• Diagnostic Kits (Tanı Kitleri) Diagnostic kits for detecting diseases and conditions in animals, supporting veterinary practitioners and livestock health management.
• Resolid CAT Turkey's first domestic combined feline vaccine, developed and manufactured by Dollvet Biyoteknoloji for feline immunization and sold to companion animal veterinarians and pet owners.
• İmmudoll CG İmmudoll CG is Dollvet's immunostimulant product for animal health, supporting immune function in livestock and other animals.

Quantifiable outcome

• Successfully exported 6 million doses of FMD vaccine to South Africa as part of a national vaccination program targeting 80% of the national herd.
• +1 more outcomes

Named customers2 records

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Two partnerships are on record, tiered core.

• South Africa Department of AgriculturecoreChannel Partner/ Reseller/ Distributor · 28 April 2026Dollvet supplied 6 million doses of FMD vaccine to South Africa's Department of Agriculture as part of a coordinated national vaccination strategy to combat a widespread FMD outbreak. The South African government activated this procurement to vaccinate 80% of the national herd of over 14 million cattle, aiming to achieve WOAH FMD-free status with vaccination and reopen international red meat export markets.
• Biogénesis BagócoreTechnology or Integration · 18 February 2026Biogénesis Bagó (Argentina) and Dollvet (Turkey) both serve as international FMD vaccine suppliers to South Africa's national vaccination program. The South African government coordinated a multi-supplier strategy sourcing vaccines from both Argentine manufacturer Biogénesis Bagó and Turkish manufacturer Dollvet to meet the volume requirements of a nationwide campaign targeting over 14 million cattle.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• Ceva Santé Animale: Global animal health company offering vaccines, pharmaceuticals, and diagnostics across livestock and companion animals. Comparable as a broader incumbent competing for the same government and livestock accounts Dollvet serves.
• MSD Animal Health (Merck Animal Health): Global animal health division of Merck offering livestock vaccines and diagnostics. Comparable as a broad incumbent providing alternative supply in large government vaccination programs.
• Phibro Animal Health: US-based animal health and nutrition company with livestock vaccine and pharmaceutical portfolio. Comparable as a broad incumbent participating in international livestock tenders, particularly in emerging markets.
• Zoetis: World's largest animal health company with full livestock vaccine and diagnostics portfolio. Comparable as a broad incumbent competitor in international livestock vaccine tenders and a benchmark for portfolio scale.
• Boehringer Ingelheim Animal Health: Top-tier global animal health player with extensive livestock vaccine franchise including FMD-adjacent products. Comparable as a broad incumbent whose portfolio competes with Dollvet's in international tenders.
• Vetoquinol: French animal health company with livestock and companion animal pharmaceuticals and biologics. Comparable as a mid-sized European incumbent competing in similar export markets.

Direct peers

• HIPRA: Spanish veterinary pharmaceutical and vaccine company with significant livestock and FMD vaccine portfolio. Directly comparable as a mid-sized, specialist animal biologics manufacturer targeting government and export customers.
• Biogénesis Bagó: Argentine veterinary vaccine manufacturer and Dollvet's co-supplier to South Africa's FMD vaccination program. Directly comparable as a national-origin animal vaccine exporter competing for the same government tenders.
• Indian Immunologicals Limited: Indian veterinary vaccine and biologic manufacturer with strong emerging-market export presence. Comparable as a developing-market producer scaling FMD and livestock vaccines for government vaccination programs.

Regional players

• Vetal Hayvan Sağlığı: Turkish veterinary pharmaceutical and vaccine producer operating in the same domestic market. Comparable as a regional competitor in Turkey's livestock vaccine and biologics segment.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/Dollvettr

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Dollvet